LeMaitre to Participate in Upcoming Investor Conferences

(NasdaqGM:LMAT), BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, November 18, 2025Waldorf Hilton, LondonDorian LeBlanc, CFO, will present at 8:00 AM GMT Wolfe Research 7th Annual Healthcare Conference Wednesday, November 19, 2025Wolfe NYC Offices, […]

LeMaitre to Participate in Upcoming Investor Conferences

LeMaitre to Participate in Upcoming Investor Conferences GlobeNewswire November 12, 2025 BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, November 18, 2025Waldorf Hilton, LondonDorian LeBlanc, CFO, will present at 8:00 AM GMT Wolfe Research

Brunswick Corporation Announces Cash Tender for an Aggregate Principal Amount of up to $50,000,000 of its 5.100% Senior Notes due 2052

(NYSE:BC), METTAWA, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) (“Brunswick” or “the Company”) announced today that it has commenced a tender offer (the “Offer”) to purchase for cash an aggregate principal amount of up to $50,000,000 (the “Tender Cap”) of its 5.100% Senior Notes due 2052 (the “Notes”). The following table

ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged — Hagens Berman

(NASDAQ:ATYR), SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) — A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The new class action, King v. aTyr Pharma Inc., filed in the U.S. District

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

(NASDAQ:ANNX), BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (NASDAQ: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has commenced an underwritten public offering of $75 million of shares of its common stock or pre-funded warrants

Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M

Transaction streamlines Edgewell's portfolio and allows the personal care brand to focus on areas of competitive leadership Edgewell Personal Care Company (NYSE: EPC) today announced that it has entered into a definitive agreement to sell its feminine care business to Essity, a leading global health and hygiene company based in Sweden, for $340 million. https://mma.prnewswire.com/media/287050/Edgewell_v1_Logo.jpg

Brunswick Corporation Announces Cash Tender for an Aggregate Principal Amount of up to $50,000,000 of its 5.100% Senior Notes due 2052

Brunswick Corporation Announces Cash Tender for an Aggregate Principal Amount of up to $50,000,000 of its 5.100% Senior Notes due 2052 GlobeNewswire November 12, 2025 METTAWA, Ill., Nov. 12, 2025 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) (“Brunswick” or “the Company”) announced today that it has commenced a tender offer (the “Offer”) to purchase for

ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged — Hagens Berman

ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged — Hagens Berman GlobeNewswire November 12, 2025 SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) — A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire November 12, 2025 BRISBANE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Annexon, Inc. (NASDAQ: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing complement-mediated diseases of the body, brain, and eye, today announced that it has commenced an underwritten

LogicMark, Inc. Announces Third Quarter 2025 Results

(PinkSheets:LGMK),(Pinksheets:LGMK),(Pinksheets:LGMKD),(PinkSheets:LGMKD), LOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) — LogicMark, Inc. (OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced financial and operational results for the third quarter ended September 30, 2025. Summary Highlights: Revenues increased 8%

Scroll to Top